OLIVERO, BARBARA
OLIVERO, BARBARA
Universita' degli Studi di MILANO
Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies
2017 P. Rebulla, S. Vaglio, F. Beccaria, M. Bonfichi, A. Carella, F. Chiurazzi, S. Coluzzi, A. Cortelezzi, G. Gandini, G. Girelli, M. Graf, P. Isernia, G. Marano, M. Marconi, R. Montemezzi, B. Olivero, M. Rinaldi, L. Salvaneschi, N. Scarpato, P. Strada, S. Milani, G. Grazzini
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma
2011 D. Vincenti, A. Ferrario, N. Orofino, M. Goldaniga, F. Rossi, C. Annaloro, E. Tagliaferri, F. Onida, B. Olivero, L. Baldini
Role of positron emission tomography in indolent non Hodgkin lymphomas
2011 F. Rossi, A. Ferrario, B. Olivero, M. Goldaniga, D. Vincenti, N. Orofino, M. Castellani, P. Gerundini, L. Baldini
Post-transplant lymphoproliferative disorders in liver and kidney recipients : a single institution experience
2011 A. Ferrario, D. Vincenti, F. Rossi, N. Orofino, B. Olivero, M. Goldaniga, L. Cro, L. Baldini
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant
2011 F. Spina, V. Montefusco, C. Crippa, A. Citro, S. Sammassimo, B. Olivero, S. Gentili, M. Galli, T. Guglielmelli, D. Rossi, A.P. Falcone, M. Grasso, F. Patriarca, M. De Muro, P. Corradini
Fludarabine, cyclophosphamide and rituximab in patients with advanced untreated indolent B-cell non-follicular lymphomas : final result of phase two study of Fondazione Italiana Linfomi (FIL)
2011 A. Ferrario, A. Pulsoni, B. Olivero, G. Rossi, F. De Angelis, U. Vitolo, A. Tedeschi, F. Merli, L. Rigacci, C. Stelitano, M. Goldaniga, D. Mannina, P. Musto, F. Rossi, E. Runggaldier, E. Gamba, L. Baldini
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial
2010 A. Ferrario, M. Goldaniga, F. Merli, V. Callea, F. Ilariucci, C. Stelitano, M. Russo, P. Mazza, S. Luminari, L. Marcheselli, M. Brugiatelli, D. Luisi, F. Rossi, B. Olivero, G. Lambertenghi Deliliers, M. Federico, L. Baldini
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma
2010 A. Ferrario, A. Aghemo, M. Goldaniga, F.G. Rossi, E. De Gasperi, A. Fracanzani, B. Olivero, L. Cro, S. Fargion, G. Lambertenghi Deliliers, L. Baldini
Indolent B-cell lymphomas treated upfront with antiviral therapy : a series of 13 patients
2010 A. Ferrario, A.M. Aghemo, M.C. Goldaniga, M. Merli, D. Vincenti, F.G. Rossi, E. Degasperi, B. Olivero, L. Cro, S. Rattotti, L. Arcaini, F. Onida, L. Baldini
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma
2010 A. Ferrario, F. Radaelli, M. Goldaniga, F.I. Grifoni, B. Olivero, F.G. Rossi, L. Baldini
Lamivudine prophylaxis of hepatitis B reactivation in anti-HBC seroposivive patients undergoing chemotherapy for onco-hematological diseases
2009 M. Viganò, B. Olivero, P. Lampertico, D. Vincenti, M.C. Goldaniga, F. Facchetti, L. Baldini, A. Cortelezzi, G. Lambertenghi Deliliers, M. Colombo
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors
2008 L. Cro, A. Ferrario, N. Zucal, U. Gianelli, S. Fabris, L. Nobili, B. Olivero, F.G. Rossi, L. Baldini, G. Lambertenghi Deliliers
Front-line treatment of low-grade non-follicular non-hodgkin lymphoma : final report of GISL LL02 trial
2007 M. Goldaniga, F. Merli, C. Stelitano, V. Callea, F. Ilariucci, M. Russo, P. Mazza, S. Luminari, F. Rossi, M. Brugiatelli, D. Luisi, B. Olivero, G. Lambertenghi Deliliers, M. Federico, L. Baldini